Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to 0.31%.

  • Tandem Diabetes Care's Return on Capital Employed fell 1200.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.14% for FY2024, which is 1500.0% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Return on Capital Employed stood at 0.31%, which was down 1200.0% from 0.31% recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Return on Capital Employed peaked at 0.04% during Q3 2021, and registered a low of 0.31% during Q3 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.19% (2024), whereas its average is 0.15%.
  • In the last 5 years, Tandem Diabetes Care's Return on Capital Employed crashed by -2900bps in 2023 and then soared by 1700bps in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Return on Capital Employed stood at 0.03% in 2021, then plummeted by -445bps to 0.1% in 2022, then tumbled by -196bps to 0.31% in 2023, then surged by 55bps to 0.14% in 2024, then tumbled by -127bps to 0.31% in 2025.
  • Its Return on Capital Employed was 0.31% in Q3 2025, compared to 0.31% in Q2 2025 and 0.27% in Q1 2025.